Skip to main content

Table 1 List of antibodies

From: Multiple biomarker tissue arrays: A computational approach to identifying protein-protein interactions in the EGFR/ERK signalling pathway

ANTIBODY & EGFR correlationp-value

COMPANY

DILUTION

PRETREATMENT

POSITIVE CONTROL

Hif1-α (p = 0.046)

Abcam

1:1500

Citrate

Squamous cell Carcinoma

VHL (p = 0.114)

ABR

Ready to use

Citrate

Healthy Kidney

VEGF (p = 0.755)

Sta Cruz

1:100

Citrate

Healthy Kidney

Flk-1 (p = 0.001)

Sta Cruz

1:50

Citrate

Healthy Kidney

CAIX (p = 0.538)

Abcam

1:500

Citrate

Renal cell carcinoma

EGFR

Dako

1:25

Proteinase K

Squamous cell Carcinoma

PDGFR-α (p = 0.320)

Sta Cruz

1:200

Citrate

Ovarian Carcinoma

PDGFR-β (p = 0.000)

Serotec

1:40

EDTA

Breast Carcinoma

TGF-α (p = 0.260)

LabVision

Ready to use

Citrate

Anterior Pituitary

TGF-β (p = 0.456)

Millipore

1:500

Citrate

Colon Carcinoma

C-KIT (p = 0.182)

Dako

1:50

No required

GIST

NOTCH1 (p = 0.052)

Abcam

3ug/ml

Citrate

Healthy Kidney

NOTCH2 (p = 0.937)

Lifespan

1:250

Citrate

Healthy Kidney

NOTCH3 (p = 0.249)

Sta Cruz

1:50

Citrate

Healthy Kidney

NOTCH4 (p = 0.337)

Sta Cruz

1:100

Citrate

Healthy Kidney

JAGGED1 (p = 0.058)

Sta Cruz

1:50

EDTA

Astrocytoma

DLL1 (p = 0.175)

Serotec

10ug/ml

EDTA

Healthy Kidney

DLL3 (p = 0.049)

Aviva

15ug/ml

Citrate

Healthy Kidney

DLL4 (p = 0.046)

Serotec

10ug/ml

Citrate

Healthy Kidney

p53 (p = 0.696)

Dako

1:50

EDTA

Breast Carcinoma

BAX (p = 0.077)

Abcam

Ready to use

EDTA

Amygdala

MDM2 (p = 0.394)

Abcam

1.5ug/ml

Citrate

Squamous cell Carcinoma

Survivin (p = 0.218)

Sta Cruz

1:100

Citrate

Breast Carcinoma

BCL2 (p = 0.000)

Dako

1:75

EDTA

Amygdala

Glut-1 (p = 0.296)

Abcam

Ready to use

Citrate

Healthy Esophagous

Glut-2 (p = 0.328)

Sta Cruz

1:50

Citrate

Liver

Glut-3 (p = 0.529)

Abcam

1:25

Citrate

Placenta

Glut-4 (p = 0.933)

Abcam

1:250

Citrate

Hearth

Glut-5 (p = 0.006)

Abcam

1:250

Citrate

Healthy Small intestine